This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy
A pioneer in hypodermic needle innovation, we offer a comprehensive platform of precision-engineered needle and needle stick prevention technologies ready for your most challenging applications and high-through put processing environments. We work with you to design needles suited to ensure the therapeutic success of your drug product.
Needles
32.5G Needle for Pen Injectors
34G Needle for Pen Injectors
Needle
Safety Hypodermic Needles
3-part Syringe
Terumo Pharmaceutical Solutions has decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to the latest stages of product commercialization to optimize critical aspects of parenteral drug delivery. We have a complete portfolio of injection, infusion, and primary packaging solutions.
Integrating the best of Terumo Pharmaceutical Solutions’ needle technology with interlocking color-coded wings
Prefillable and engineered for compatibility with a broad range of therapeutics
Innovation and creativity are central to our Pharmaceutical Solutions Division value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.
October 8 - 10 Biarritz, France
October 8 - 10 Milan, Italy
October 22 - 23 Phoenix, USA
October 28 - 29 Boston, USA
November 26 - 28 Delhi, India
This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.
This is HCP only content